Larvol Delta - Diakonos-Oncology-Announces-Study-to-Continue-after-First-DSMB-Safety-Review-of-DOC1021-in-Phase-2-GBM-Study

dubodencel (DOC1021) - Diakonos Research

https://www.prnewswire.com/news-releases/diakonos-oncology-announces-study-to-continue-after-first-dsmb-safety-review-of-doc1021-in-phase-2-gbm-study-302688898.html

Feb 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next